NeuroOne Medical Technologies Corporation
NMTC
$0.567
-$0.0126-2.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.64% | -3.87% | -19.84% | -36.36% | -50.94% |
| Total Depreciation and Amortization | 14.00% | 23.83% | 44.07% | 65.24% | 71.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.83% | 67.58% | 14.09% | 13.65% | 0.69% |
| Change in Net Operating Assets | -71.65% | 60.69% | -185.66% | -1.63% | -55.87% |
| Cash from Operations | 47.03% | 14.55% | -25.45% | -36.54% | -58.46% |
| Capital Expenditure | 73.76% | 68.71% | 64.12% | 13.72% | -81.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 206.06% | 201.94% |
| Cash from Investing | -104.14% | -104.54% | 60.25% | 159.34% | 182.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -53.14% | -31.66% | 333.71% | 1,086.30% | -- |
| Repurchase of Common Stock | 40.57% | 31.88% | 27.68% | 53.70% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 193.26% | 238.14% | -357.39% | -472.12% | -6,735.00% |
| Cash from Financing | -35.55% | -1.75% | 349.35% | 1,434.58% | 53,973.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.14% | -36.10% | 79.37% | 87.40% | 82.75% |